Printed from https://fyi.org.nz/similar/request/21102-rolling-reviews-of-safety-efficacy-of-non-mrna-gene-therapy-covid-19-treatments on September 23, 2025 23:12

Requests similar to 'Rolling reviews of safety & efficacy of (non-mRNA gene therapy) COVID-19 treatments'

Communications regarding funding of Freestyle Libre monitors
Response by Pharmaceutical Management Agency to Harry Peterson on .
Awaiting classification.
  Kia ora please see attached 😊   Arihia Gray [1](she/her) | Policy advisor 9 December 2022 J Burning [email address] Tēnā koe J Burning Request...
Stimulant medicine ADHD lisdexamfetamine - clear health benefit - efficacy and safety data
Request sent to Pharmaceutical Management Agency by J Bruning on .
Awaiting classification.
Pharmac’s decision to fund (the now generic) lisdexamfetamine, a new stimulant medicine that will provide an additional treatment option for people...
Remdesivir costs $4400 per person - Covid 19: European study finds no clinical benefit
Follow up sent to Pharmaceutical Management Agency by Micky Turner on .
Successful.
Hi Melody, Thanks for providing the information! Here is a summary of the details: Remdesivir is a failed Ebola drug. It was designed to treat E...
Testing and Therapeutics Technical Advisory Groups documents
Response by Ministry of Health to Harold on .
Successful.
  Kia ora Harold   Please find attached a response to your request for official information [H202204655]. Please accept our apologies for the de...
Molnupiravir for Horses, Zebras & Donkeys - offspring born with no teeth & skull missing
Response by Pharmaceutical Management Agency to Micky Turner on .
Successful.
Kia ora Micky Please find a response for your request for information attached with this email. Ngā mihi Simon Simon Mitchell | Senior Policy Adviso...
Medical Advice for COVID Infected People Isolating at Home
Response by Ministry of Health to Chris Johnston on .
Partially successful.
Tēnā koe Chris     Thank you for your ​follow up request under the Official Information Act 1982 (the Act) to the Ministry of Health (the Ministry...
Supporting/supplementary documentation to the 1 & 2 November 2018 PTAC minutes on funding of Whole Thyroid Extract and Liothyronine
Response by Pharmaceutical Management Agency to Belinda Hodson on .
Awaiting classification.
Good morning Belinda Please find attached PHARMAC's response to your recent request for information about the funding of Whole Thyroid Extract and Lio...
Assessment bias toward new medicines - Ivermectin and Pfizer antiviral PF-07321332
Response by Ministry of Health to Adam Irish on .
Partially successful.
Kia ora Adam, Thank you for your request for official information received on 29 November 2021 for:   “What systems are in place to ensure that...
Has Pharmac Ever Funded A Sativex Prescritpion?
Response by Pharmaceutical Management Agency to Gregory Soar on .
Successful.
Dear Mr Soar, Please find attached letter regarding your OIA request on 26 June 2015. Kind regards Alexis Poppelbaum         PHARMAC 24 July 20...
Monoclonal antibodies
Response by Ministry of Health to M.R.M. on .
Long overdue.
Kia ora M.R.M Please find attached a letter regarding your request for information. Ngā mihi OIA Services Government Services Office of the Dir...
Which thyroid medications and bio-identical T4, T3 equivalents meet criteria for government funding
Response by Pharmaceutical Management Agency to Belinda Hodson on .
Successful.
Good morning Ms Hodson, Please find attached PHARMAC’s response to your OIA request. Kind regards Alexis Poppelbaum         PHARMAC 28 August 2...
COVID-19 Early Treatment Options
Response by Ministry of Health to Micky Turner on .
Successful.
Tçnâ koe Micky   Thank you for your request under the Official Information Act 1982 (the Act) to the Ministry of Health (the Ministry) on 13 Novem...
COVID19 treatment and mitigation alternatives
Response by Ministry of Business, Innovation & Employment to Robin Benson on .
Successful.
Good afternoon Mr Benson,   Please see attached MBIE’s response to your official information act request.   Kind regards, Lisa   Ministe...
Supporting evidence to debunked misconceptions as published by the Nz Herald in support of the MoH
Response by Ministry of Health to Nastassja Catmull-Gillespie on .
Awaiting classification.
Tçnâ koe Nastassja     Thank you for your request under the Official Information Act 1982 (the Act) to the Ministry of Health (the Ministry) on...
Review of the Evidence regarding Effectiveness of Ivermectin in Treatment of Covid-19
Response by Ministry of Health to Adrian O'Flynn on .
Awaiting classification.
Kia ora Adrian O’Flynn     Please find attached a letter regarding your request for information.     Ngâ mihi     OIA Services Gove...
Provide information of care and therapy offered people who are hospitalised with Covid-19 symptoms
Response by Ministry of Health to greg rzesniowiecki on .
Partially successful.
Kia ora Greg     Thank you for your request for official information on 27 August 2021 for:                   “Please provide information rega...
Equity of access for low side-effect formulations for therapeutic treatment of anxiety, depression & ADHD
Request sent to Ministry of Health by J Bruning on .
Successful.
Please consider that this OIA request is urgent and so concerns the processes for applicants as the law and secondary legislation currently stands....
Budget 2025: Extent of funding for nutrition-related policy & work programmes
Request sent to Shane Reti by J Bruning on .
Successful.
Increasingly, conventional medical clinicians and general practitioners operate with one arm behind their back, on the surface, oblivious in the fac...
Dispensed drugs, media and events information request
Response by Pharmaceutical Management Agency to Joe Heihei on .
Awaiting classification.
Dear Joe   Please see attached the response to your OIA request.     Kind regards Dean Zeng PHARMAC   25 May 2018 Dear Joe REQUEST FO...
People using PrEP contracting HIV
Response by Pharmaceutical Management Agency to The Magic Roast on .
Partially successful.
Hi Jacky, huge apologies! Here is our response. Have a lovely weekend Jane Jacky Thorndon [FOI #9905 email] 26 April 2019 Dear Jacky, REQUEST FOR I...
DHB Treatment Protocols
Response by Ministry of Health to Michael Vaughan on .
Awaiting classification.
Dear Michael   Northland DHB’s response to your recent Official Information Act request is attached..   Regards Kathryn Leydon   Directo...
Information regarding Dexcom CGMS and Libre FGMS
Response by Pharmaceutical Management Agency to D Smith on .
Awaiting classification.
Kia ora D Smith   Further to our previous email to you on Friday 19 March 2021, please find attached the final response to your request for inform...
Risk assessment of vaccinated person contracting Covid-19 from an un-vaccinated person
Response by Chris Hipkins to Helen Wallis on .
Partially successful.
Kia ora Helen On behalf of Hon Chris Hipkins, Minister for COVID-19 Response, thank you for your request under the Official Information Act 1982 (the...
Why have you restricted Ivermectin?
Response by Pharmaceutical Management Agency to Annie Weston on .
Successful.
Mōrena Annie Please find a response to your request about ivermectin attached with this email. Ngā mihi Melody Willis (she/her) | Government Servic...
Discontinuation of Phenelzine Sulphare
Response by Pharmaceutical Management Agency to Megs on .
Successful.
Dear Megs Attached is PHARMAC's response to your recent information request. Kind regards PHARMAC | Te Pātaka Whaioranga | PO Box 10 254 | Level 9,...